IDSA update from the city of brotherly love.

  • Raj Ghandi
  • Published 2000 in
    The Hopkins HIV report : a bimonthly newsletter…


Data from a major new trial called START II (Selection of Thymidine Analog Therapy), was presented at this year's Infectious Diseases Society of America (IDSA) conference. One trial compared d4T/ddI/IDV combination therapy with AZT/3TC/IDV in treatment-naive individuals. A second trial, CNA 3003, compared triple NRTI therapy with AZT/3TC/abacavir to dual… (More)


1 Figure or Table